DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 141 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,053,369 | +26.8% | 182,847 | +40.1% | 0.01% | +18.2% |
| Q1 2024 | $1,619,529 | -34.6% | 130,502 | -26.3% | 0.01% | -31.2% |
| Q4 2023 | $2,474,543 | +388.6% | 177,006 | +271.9% | 0.02% | +300.0% |
| Q4 2022 | $506,464 | -16.0% | 47,600 | -17.6% | 0.00% | -20.0% |
| Q3 2022 | $603,000 | +59.9% | 57,750 | +65.9% | 0.01% | +66.7% |
| Q1 2022 | $377,000 | +55.1% | 34,800 | +101.2% | 0.00% | +50.0% |
| Q4 2021 | $243,000 | -33.8% | 17,300 | -79.6% | 0.00% | -71.4% |
| Q3 2020 | $367,000 | -49.9% | 84,834 | +76.4% | 0.01% | -82.5% |
| Q2 2018 | $733,000 | +40.4% | 48,100 | +82.8% | 0.04% | +2.6% |
| Q1 2018 | $522,000 | +13.0% | 26,308 | +6.5% | 0.04% | +2.6% |
| Q4 2017 | $462,000 | +158.1% | 24,699 | +44.7% | 0.04% | +26.7% |
| Q3 2016 | $179,000 | – | 17,070 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
| Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
| Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
| Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
| Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
| RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
| Maven Securities LTD | 264,989 | $931,000 | 0.29% |
| Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
| GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |